GlaxoSmithKline is to scrap individual sales targets for its commercial staff as it seeks to repair its image and reform working practices after allegations in China that its staff paid officials up to $500m in bribes.
葛蘭素史克(GlaxoSmithKline, GSK)將取締針對商業部門員工的個人銷售目標。在其中國員工被指向政府官員行賄高達5億美元后，這家藥業巨擘正尋求修復自身形象，改革工作方式。
您已閱讀9%（310字），剩餘91%（3269字）包含更多重要資訊，訂閱以繼續探索完整內容，並享受更多專屬服務。